Researchers identified three chromosome 21 genes that are overactive in brain cells of individuals with Down syndrome, and ...

Scientists from Duke-NUS Medical School, working with collaborators at Imperial College London and partners in Europe and the United States, have uncovered new insights into how an additional copy of ...

The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

Statement outlines first-contact Primary Care PT supported by point-of-care MSK Utrasound and EMG/NCS testing, ...

Engineering and social sciences are widely considered to be separate fields of practice. However, all technology we develop has the capacity to shape the society in which it is applied.

Scientists from Duke-NUS Medical School, working with collaborators at Imperial College London and partners in Europe and ...

This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, NE / ACCESS Newswire / February 26, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a ...

For more than thirty years, FINEOS has focused exclusively on the life, accident and health (LA&H) insurance industry, helping carriers around the world modernise their operations and deliver ...

Spells of school absence of one to two days at age 13 are linked to lower Leaving Certificate grades, a report from the ...

A local gymnastics program is working to fill a gap in recreational options for children with disabilities by combining occupational therapy with adaptive and inclusive gymnastics.

Models that provide hybrid payments to primary care practices without adding financial risk are effective at supporting the ...